Search Results

There are 4484 results for: content related to: Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice

  1. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Article first published online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  2. You have free access to this content
    How to optimize HCV therapy in genotype 1 patients: predictors of response

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 23–29, Salvatore Petta and Antonio Craxì

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12053

  3. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

    Liver International

    Volume 35, Issue 9, September 2015, Pages: 2090–2099, Patrick Miailhes, Camille Gilbert, Karine Lacombe, Joop E. Arends, Massimo Puoti, Jürgen K. Rockstroh, Philippe Sogni, Hélène Fontaine, Eric Rosenthal, Maria Winnock, Marc-Arthur Loko, Linda Wittkop, François Dabis, Dominique Salmon and the ESCMID European Study Group on Viral Hepatitis

    Article first published online : 23 FEB 2015, DOI: 10.1111/liv.12799

  4. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy

    Liver International

    Volume 34, Issue 7, August 2014, Pages: 1018–1024, James F. Crismale, Valérie Martel-Laferrière, Kian Bichoupan, Emily Schonfeld, Alexis Pappas, Christina Wyatt, Joseph A. Odin, Lawrence U. Liu, Thomas D. Schiano, Ponni V. Perumalswami, Meena Bansal, Douglas T. Dieterich and Andrea D. Branch

    Article first published online : 25 OCT 2013, DOI: 10.1111/liv.12342

  5. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  6. You have free access to this content
    HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians

    Liver International

    Volume 32, Issue 8, September 2012, Pages: 1194–1199, Patrick Ingiliz and Jürgen K. Rockstroh

    Article first published online : 17 APR 2012, DOI: 10.1111/j.1478-3231.2012.02796.x

  7. You have free access to this content
    Management of HCV transplant patients with triple therapy

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 46–52, Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée and Didier Samuel

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12406

  8. Drug–drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1557–1565, Elena González-Colominas, Teresa Broquetas, Alexandra Retamero, Montserrat García-Retortillo, Nuria Cañete, Susanna Coll, Rosa Pellicer, Maria D. Giménez, Beatriz Cabrero, Felipe Bory, Hernando Knobel, Esther Salas, Ricard Solà and José A. Carrión

    Article first published online : 15 DEC 2014, DOI: 10.1111/liv.12729

  9. Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients

    Liver International

    Volume 36, Issue 1, January 2016, Pages: 49–58, Francesca Lupo, Roberta Russo, Achille Iolascon, Donatella Ieluzzi, Angela Siciliano, Pierluigi Toniutto, Alessandro Matté, Sara Piovesan, Elena Raffetti, Francesco Turrini, Denis Dissegna, Francesco Donato, Alfredo Alberti, Valeria Zuliani, Giovanna Fattovich and Lucia De Franceschi

    Article first published online : 14 JUL 2015, DOI: 10.1111/liv.12900

  10. You have full text access to this OnlineOpen article
    Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 21, Issue 5, May 2014, Pages: 341–347, Y. Karino, I. Ozeki, S. Hige, M. Kimura, T. Arakawa, T. Nakajima, Y. Kuwata, T. Sato, T. Ohmura and J. Toyota

    Article first published online : 25 AUG 2013, DOI: 10.1111/jvh.12162

  11. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 869–889, Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal and Stanislas Pol

    Article first published online : 25 NOV 2013, DOI: 10.1111/liv.12363

  12. The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 3, March 2015, Pages: 254–262, T. Oze, N. Hiramatsu, T. Yakushijin, R. Yamada, N. Harada, N. Morishita, M. Oshita, E. Mita, T. Ito, Y. Inui, M. Inada, S. Tamura, H. Yoshihara, Y. Imai, M. Kato, T. Miyagi, Y. Yoshida, T. Tatsumi, A. Kasahara, N. Hayashi and T. Takehara

    Article first published online : 31 JUL 2014, DOI: 10.1111/jvh.12289

  13. You have free access to this content
    Management of HCV patients with cirrhosis with direct acting antivirals

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 38–45, Vincenzo Boccaccio and Savino Bruno

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12391

  14. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

    The Journal of Clinical Pharmacology

    Volume 55, Issue 10, October 2015, Pages: 1147–1156, Sivi Ouwerkerk-Mahadevan, Atef Halabi, Blanka Cieslarová, Indra Aerts, James Witek, Rodica Van Solingen-Ristea and Donghan Luo

    Article first published online : 7 JUL 2015, DOI: 10.1002/jcph.545

  15. Incidence of virological failure and emergence of resistance with twice-daily vs every 8-h administration of telaprevir in the OPTIMIZE study

    Journal of Viral Hepatitis

    Volume 21, Issue 12, December 2014, Pages: 835–842, I. Dierynck, A. Ghys, J. Witek, D. Luo, K. Janssen, B. Daems, G. Picchio, M. Buti and S. De Meyer

    Article first published online : 17 NOV 2014, DOI: 10.1111/jvh.12347

  16. Fatigue-induced changes in tonic vibration response (TVR) in humans: Relationships between electromyographic and biochemical events

    Muscle & Nerve

    Volume 38, Issue 5, November 2008, Pages: 1481–1489, Christelle Brerro-Saby, Stéphane Delliaux, Jean Guillaume Steinberg and Yves Jammes

    Article first published online : 24 SEP 2008, DOI: 10.1002/mus.21117

  17. Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1165–1171, Kazuto Fukuda, Yasuharu Imai, Naoki Hiramatsu, Keiko Irishio, Takumi Igura, Yoshiyuki Sawai, Sachiyo Kogita, Yuki Makino, Rui Mizumoto, Yasushi Matsumoto, Masanori Nakahara, Sinichiro Zushi, Nobuyuki Kajiwara, Tsugiko Oze, Sumio Kawata, Norio Hayashi and Tetsuo Takehara

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12229

  18. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27516

  19. Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients

    Hepatology Research

    Volume 43, Issue 7, July 2013, Pages: 691–701, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Yuya Seko, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saito, Yasuji Arase, Kenji Ikeda, Rie Mineta, Sachiyo Watahiki, Mariko Kobayashi, Yoshiyuki Nakayasu, Hidetaka Tsuda, Keiji Aoki, Ichimaro Yamada and Hiromitsu Kumada

    Article first published online : 29 NOV 2012, DOI: 10.1111/hepr.12009

  20. Botulinum toxin changes intrafusal feedback in dystonia: A study with the tonic vibration reflex

    Movement Disorders

    Volume 21, Issue 6, 6 June 2006, Pages: 777–782, Carlo Trompetto, Antonio Currà, Alessandro Buccolieri, Antonello Suppa, Giovanni Abbruzzese and Alfredo Berardelli

    Article first published online : 6 FEB 2006, DOI: 10.1002/mds.20801